GlassScriptPhysician profile
Christopher J Walker
NPI 1023217866
$1,514.40
in general payments reported to CMS, 2019-2025
16 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $399 · 2023: $469 · 2024: $293 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.72 | 2022-2025 | |
| Lilly USA, LLC | $276.43 | 2022-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $203.00 | 2022-2025 | Breztri, Airsupra |
| Pfizer INC. | $181.90 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $140.83 | 2022 | |
| Amgen INC. | $93.36 | 2023-2025 | Repatha, Otezla, Otezla |
| Vanda Pharmaceuticals INC. | $88.81 | 2022-2024 | Fanapt, Hetlioz |
| Exact Sciences Corporation | $51.69 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $50.07 | 2022-2023 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $30.70 | 2023-2024 | Xarelto |
| Allergan, INC. | $28.69 | 2022 | |
| Organon LLC | $18.91 | 2025 | Nexplanon |
| Alkermes, INC. | $18.75 | 2025 | Vivitrol |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.63 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.55 | 2024 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.